The global mouth ulcers treatment market was valued at 1,655.00 million in 2020, and is projected to reach $2,375.70 million by 2030, registering a CAGR of 3.8% from 2021 to 2030. Mouth ulcers are painful breaks, sores or lesions that occur in the mucous membrane of the oral cavity's soft tissues, which include the lips, cheeks, gums, tongue, floor, and roof. It can also be seen on the esophagus. It is often unpleasant light or yellow lesions with a crimson outer ring that is painful and cause discomfort while drinking and eating food.
Aphthous stomatitis, commonly known as recurrent aphthous ulcers or canker sores, is a frequent oral mucosal disease seen by doctors and dentists. Aphthous ulcers are tiny, shallow lesions that form on the soft tissues of the mouth or at the base of the gums. Canker sores, unlike cold sores, do not appear on the surface of the lips and are not communicable. They are often merely a mild annoyance that lasts a week or two. They are exceedingly frequent, occurring in conjunction with a broad variety of illnesses and by a number of processes, although there is generally no significant underlying cause. They can be painful and make eating and talking difficult.
The demand for mouth ulcers treatment has been on a rise due to increasing prevalence of mouth ulcers due to rise in tobacco consumption globally and smoking cessation, as smoking cessation causes mouth ulcers and occur often in smokers. Therefore, this increases the occurrences of mouth ulcers due to tobacco stomatitis or smoker's palate, (inflammation of mucus membranes in oral cavity), which is expected to propel the market growth of mouth ulcers treatment.
Moreover, use of chemical-based toothpaste and consumption of more citric foods or acidic fruits and vegetables, such as lemons, oranges, pineapples, apples, figs, tomatoes, strawberries, further increase the chances of mouth ulcers. Therefore, rising tobacco usage, smoking cessation, chemical-based toothpaste, and acidic foods are the factors that are driving the growth of the mouth ulcers treatment market.
Oral hygiene is the practice of keeping one's mouth clean, free of disease, and other dental conditions. There has been an increasing demand for oral and dental hygiene mainly due to self-consciousness. Mouth ulcers occur often as a result of infection from plaque bacteria on the teeth; poor oral hygiene also plays a contributory role in the development of mouth ulcers. Self-consciousness among individuals for oral and dental hygiene has been on rise, including orthodontic, periodontics, endodontic, and various other cosmetic dentistry services. Injury from orthodontic braces, which are used for alignment of the teeth, poor-fitting dentures, and other apparatus that may rub against the mouth and gums is one of the causes of occurrence of mouth ulcers.
Various bacterial, viral, and fungal infections caused by poor oral hygiene can trigger mouth ulcer while minor injuries due to sports or any other activities in oral cavity also lead to mouth ulcers and infections. Canker ulcers also occur due to certain nutritional deficiencies. Thus, various factors, such as mouth ulcers due to orthodontics braces, minor injuries and various initiatives by the government and dental associations for the importance of oral hygiene, are expected to drive the mouth ulcers treatment market. Therefore, it is expected to create a positive impact during the forecast period.
Increase in overall population, especially the geriatric, has led to the increase in cases of people having mouth ulcers or sores. Mouth ulcers as a result of various medical condition or nutritional deficiencies, such as celiac or Crohn's disease, vitamin B12 or iron deficiency, or a weakened immune system, in elderly population may all trigger ulcers or sores to form. These oral health problems and illnesses connected with aging are frequently complicated and can have a negative impact on one's quality of life. Any oral diseases or conditions associated with aging are complex and can have a significant effect on the quality of life for geriatric population.
In addition, increasing overall population specific geriatric and unhealthy lifestyle changes, stress, anxiety, tobacco use, and consumption of more chemical & acidic-based food in younger generation led to repetitive occurrences of mouth ulcers. Thus, all these factors are expected to contribute toward driving the mouth ulcers treatment market.
In addition, there are opportunities in untapped, emerging markets with high potential due to improved healthcare infrastructure, increase in unmet healthcare needs, and rise in prevalence of mouth ulcers. Availability of various pharmaceutical-based ulcer treatment products, such as drugs, including analgesics, corticosteroids, antihistamine, antimicrobial, anesthetic, various applicants in the form of sprays, mouthwash, gels, lozenges, ointments, and others at affordable cost and their availability as an OTC product is an emerging opportunity for the key players of the market to invest in the mouth ulcers treatment market, which will further accelerate the expansion of the market, thereby offering significant growth opportunities for the market during the forecast period.
Mouth Ulcers Treatment Market Segmentation
The mouth ulcers treatment market is segmented on the basis of drug class, formulation type, indication, and region. On the basis of drug type, the market is categorized into analgesics & corticosteroids, antihistamine, antimicrobial, and anesthetic. By formulation type, the market is divided into sprays, mouthwash, gels, and lozenges. By indication, the market is classified into aphthous stomatitis, oral lichen planus, and others.
Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and the rest of LAMEA).
Segment review
Depending on drug class, the anesthetic segment dominated the market in 2020, and is expected to continue this trend during the forecast period due to increase in demand for painkillers for temporarily reducing unbearable pain and discomforts due to mouth ulcers and also their anti-inflammatory properties.
By Drug Class
Anesthetic segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.
On the basis of formulation type, the gels segment led the market in 2020, and is expected to retain its dominance during the forecast period, owing to its popularity due to quick healing formulations, ease of availability, immediate anti-inflammatory, and anti-swelling qualities.
By Formulation Type
Gels segment is projected as one of the most lucrative segment.
By indication, the aphthous stomatitis segment exhibited the highest growth in 2020, and is expected to continue this trend during the forecast period.
North America accounted for a majority of the global mouth ulcers treatment market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of mouth ulcers, presence of key players, increase in healthcare expenditure, advancements in technology, and rise in government initiatives in the region. However, Asia-Pacific is anticipated to witness the highest CAGR from 2021 to 2030, owing to increase in overall population and rise in trend of self-medication in the region. Furthermore, innovation and development are anticipated to further fuel the growth in this region in the near future.
By Region
Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 5.8% during the forecast period.
The key players operating in the global mouth ulcers treatment market include Blistex Inc., Bristol-Myers Squibb Company, Church & Dwight Co, Inc., Colgate Palmolive Company, Dr. Reddy’s, GlaxoSmithKline, plc, Patterson Dental Supply, Inc., Pfizer Inc., Prince Care Pharma Private Limited, and 3M.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the mouth ulcers treatment market, and the current trends and future estimations to elucidate the imminent investment pockets.
- It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
- Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
Key Market Segments
By Drug Class
- Analgesics and Corticosteroids
- Antihistamine
- Antimicrobial
- Anesthetic
By Formulation Type
- Sprays
- Mouthwash
- Gels
- Lozenges
By Indication
- Aphthous Stomatitis
- Oral Lichen Planus
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
Key Market Players
- Blistex Inc.
- Bristol-Myers Squibb Company
- Church & Dwight Co, Inc.
- Colgate Palmolive Company
- Dr. Reddy’s Laboratories Ltd.
- GlaxoSmithKline, plc
- Patterson Companies, Inc.
- Pfizer Inc.
- Prince Care Pharma Private Limited
- 3M
Mouth Ulcers Treatment Market Report Highlights
| Aspects | Details |
 By DRUG CLASS |
|
 By FORMULATION TYPE |
|
 By INDICATION |
|
 By Region |
|
 Key Market Players | BRISTOL-MYERS SQUIBB COMPANY, 1.Company overview, PATTERSON COMPANIES, INC., PRINCE CARE PHARMA PVT LTD, DR. REDDY’S LABORATORIES LIMITED, GLAXOSMITHKLINE PLC, COLGATE-PALMOLIVE COMPANY, BLISTEX INC., PFIZER, INC., CHURCH & DWIGHT CO., INC. |
Analyst Review
This section provides the opinions of the top level CXOs in the mouth ulcers market. According to the insights of CXOs, increasing prevalence of mouth ulcers due to smoking cessation and tobacco use, citric and chemicals in foods, unhealthy lifestyles leading to stress and anxiety are all attributed toward the growth of the mouth ulcers treatment market.
The CXOs further added that technological advancements in the healthcare sector for various formulation types such as rapidly healing gels for ulcers, flavored mouthwashes for children as well as adults, and surge in oral hygiene dental visits due to self-consciousness are significantly enhancing the market growth. The emerging awareness by the government and media by public advertisements as well as key players of the market advertising their products, such as mouthwashes, is expected to further boost the market.
The mouth ulcers treatment market gains interest of healthcare companies, owing to surge in demand for instant relief from ulcer pain and discomfort caused while eating or drinking and at the same time availability of various over the counter (OTC) analgesic drugs, mouthwashes, gels, and sprays. This leads to increase in adoption of pharmaceutical uses as that of traditional remedies, thus further propelling the growth of the market.
North America is expected to witness highest growth, in terms of revenue, owing to rise in prevalence of mouth ulcers, presence of key players, and advancements in healthcare investments. Asia-Pacific was the second largest contributor to the market in 2020, and is expected to register the fastest CAGR during the forecast period, owing to increase in prevalence of mouth ulcer cases and rise in population. However, presence of substitute traditional treatments and limited accessibility to pharmaceuticals in developing and under developed countries restrain the market growth during the forecast period.
The total market value of mouth ulcers treatment market is $1,655.0 million in 2020.
The forcast period for mouth ulcers treatment market is 2021 to 2030
The market value of mouth ulcers treatment market in 2021 is $ 1,704.80 million.
The base year is 2020 in mouth ulcers treatment market
Top companies such as Blistex Inc., Bristol-Myers Squibb Company, Church & Dwight Co, Inc., Colgate Palmolive Company, Dr. Reddy’s, GlaxoSmithKline, plc., Patterson Dental Supply, Inc., Pfizer Inc., Prince Care Pharma Private Limited and 3M. held a high market position in 2020.
Gel segment dominated the global market in 2020, and expected to continue this trend throughout the forecast period. The gel based products are easy to apply, provide instant relief, at the same time come in various flavours suitable for children as well as adults, are easily available, simple to use and come at an affordable cost.
Rise in incidences of tobocco consumption, rrise in smoking cases, chronic disaeses in geriatric population, various chemotherapies side effects also leads to ulcers is among the key drivers propelling market growth.
North America is projected to account for a major share of the global mouth ulcers treatment market during the forecast period. U.S. dominated the North America mouth ulcers treatment market owing to increased tobacco consumption and increasing awareness of oral an dental hygiene across the country.
Loading Table Of Content...
